© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, CollPlant Biotechnologies Ltd. (CLGN) shows an Average True Range (ATR) of 0.16 and an Enterprise Value of 38.21M. Its average trading volume over the past 3 months is 100.07K, indicating liquidity. These fundamental metrics provide insight into CLGN's underlying financial health and market activity.
CollPlant Biotechnologies Ltd. (CLGN) technical indicators as of December 22, 2025: the SMA 20 is -20.68%, SMA 50 at -27.02%, and SMA 200 at -32.85%. The RSI 14 value is 33.28, suggesting its current momentum. These technical analysis signals help assess CLGN's price trends and potential future movements.
CollPlant Biotechnologies Ltd. (CLGN) stock performance overview as of December 22, 2025: The 52-week high is $4.98 (currently -69.48% below), and the 52-week low is $1.31 (currently 16.92% above). Over the past year, CLGN's performance is -60.93%, compared to the S&P 500's 12.87% change.
According to market data, CollPlant Biotechnologies Ltd. (CLGN) stock's recent performance metrics show that over the last month, CLGN is -29.3%, with a Year-to-Date (YTD) performance of -57.78%. Over the past year, the stock has seen a -60.93% change. These figures summarize CLGN's price movements across various periods, reflecting its historical returns.
According to current financial data, CLGN stock's P/E (TTM) ratio is -1.59, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for CLGN, including P/S (7.81), P/B (2.08), and P/FCF (-1.93), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.